{
    "clinical_study": {
        "@rank": "9980", 
        "arm_group": {
            "arm_group_label": "Blood Draw", 
            "description": "Normal healthy individuals will be consented and their blood drawn at the time of their visit."
        }, 
        "brief_summary": {
            "textblock": "This study is intended to collect blood from healthy individuals to investigate whether\n      variations in immune-related (inflammasome) genes affect how the immune cells found in the\n      blood can help fight infections and prevent diseases."
        }, 
        "brief_title": "Gene Polymorphism Study of Normal Individual Inflammasome Genes", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy Individuals", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Healthy with no chronic or acute illnesses, or taking medication which in the opinion\n             of the PI would impact the analyses being conducted.\n\n          2. At least 18 years or older.\n\n          3. Are capable of reading, understanding and providing written informed consent.\n\n        Exclusion Criteria:\n\n          1. Non-English speaking.\n\n          2. Individuals under 18 years old.\n\n          3. Woman who believe they are or may be pregnant. (Based on self reporting. Pregnancy\n             testing will not be conducted for the purposes of this study)\n\n          4. Individuals experiencing acute or chronic illnesses which in the opinion of the PI\n             would impact the analyses being conducted.\n\n          5. Currently taking prescription or over the counter medication which in the opinion of\n             the PI would impact the analyses being conducted.\n\n          6. Individual has donated blood more than twice in the last week or the amount to be\n             drawn will exceed the maximum allowance in the last 8 weeks."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Normal volunteers."
            }
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01988805", 
            "org_study_id": "2012H0346"
        }, 
        "intervention": {
            "arm_group_label": "Blood Draw", 
            "intervention_name": "Blood Draw", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 14, 2013", 
        "location": {
            "contact": {
                "email": "mark.wewers@osumc.edu", 
                "last_name": "Mark Wewers, MD", 
                "phone": "614-293-4978"
            }, 
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio"
                }, 
                "name": "Davis Heart & Lung Research Institute"
            }, 
            "investigator": {
                "last_name": "Mark Wewers, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Immunological Characterization of Blood and Inflammasome Gene Segment Polymorphism Analysis of Normal Healthy Individuals", 
        "overall_contact": {
            "email": "mark.wewers@osumc.edu", 
            "last_name": "Mark Wewers, MD", 
            "phone": "614-293-4978"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Our intent is to collect these cells, divide them into subtypes such as monocytes, lymphocytes and neutrophils and then to analyze their ability to respond to exogenous challenges by changing the production of proteins, the expression of genes and their ability to migrate and ingest materials. We additionally will be interested in examining the cell components that may be released from these cells during various in vitro challenges.", 
            "measure": "analyze their ability to respond to exogenous challenges by changing the production of proteins, the expression of genes and their ability to migrate and ingest materials", 
            "safety_issue": "No", 
            "time_frame": "one visit"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01988805"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ohio State University", 
            "investigator_full_name": "Mark D. Wewers, MD", 
            "investigator_title": "Associate Director, Pulmonary Research", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ohio State University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ohio State University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}